Pharmaceutical

Boehringer and CBmed partner to develop cancer therapies

Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.

Feb 10, 2024 - 18:00
Boehringer and CBmed partner to develop cancer therapies
Boehringer has entered a strategic collaboration with CBmed to expedite the translation of cancer treatment approaches into new therapies.
Read the original article

Tags:

Previous Article

Janssen seeks EMA approval of RYBREVANT for NSCLC

Next Article

AstraZeneca posts 81% rise in FY 2023 profit after tax

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: White House to tap cancer center chief to lead NIH; generic abortion pill maker sues FDA

STAT+: Pharmalittle: White House to tap cancer center c...

Apr 21, 2023

STAT+: HHS dispatches millions to next-generation Covid targets, including intranasal vaccine

STAT+: HHS dispatches millions to next-generation Covid...

Oct 14, 2023

STAT+: British Columbia to bar Americans from buying Ozempic over supply concerns

STAT+: British Columbia to bar Americans from buying Oz...

Mar 30, 2023